CLINICAL_TRIALS
trial_result
· 2021-06-23
Clinical Trial Update: Proxalutamide Treatment for Hospitalized COVID-19 Patients [Phase 3]
Summary
Phase 3 trial update for proxalutamide in hospitalized COVID-19 patients; trial completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Applied Biology, Inc. | Conditions: Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Status: COMPLETED | Results posted: 2021-06-23